FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Advisors to Consider Avodart, Proscar Prostate Cancer Prevention

[ Price : $8.95]

FDA reviewers question the relevance of clinical trials submitted to support labeling changes for Avodart and Proscar relating the...

Gen-Probe Submits PMA for HPV Assay

[ Price : $8.95]

Gen-Probe files a PMA for its Aptima HPV (human papillomavirus) assay, a new molecular test that detects high-risk HPV infections ...

FDA Extends Review for MS Drug

[ Price : $8.95]

FDA extends by three months its review of an EMD Serono NDA for cladribine tablets as a therapy for relapsing forms of multiple sc...

FDA Sees Need to Improve NDC Directory

[ Price : $8.95]

FDA says it generally agrees with an HHS Inspector General recommendation that it do a better job of ensuring completeness and acc...

Sanofi Pasteur Trial Begins with C-diff Vaccine

[ Price : $8.95]

Sanofi Pasteur starts a Phase 2 clinical study involving a vaccine for primary prevention of Clostridium difficile infection.

Spectrum Pharma Resubmits sNDA for Fusilev

[ Price : $8.95]

FDA accepts for review a Spectrum Pharmaceuticals supplemental NDA re-submission for Fusilev (levoleucovorin) for injection for tr...

Advanced Bionics Recalls Cochlear Implants

[ Price : $8.95]

Advanced Bionics notifies FDA that it is voluntarily recalling its HiRes 90K cochlear implant devices due to two reported cases of...

FDA, Industry Move Forward on Mid-review Communications

[ Price : $8.95]

FDA and industry discuss longer user fee review times to allow for a mid-review communication for feedback from reviewers on the s...

FDA Clears Object Researchs ORS Visual Software

[ Price : $8.95]

FDA clears an Object Research Systems 510(k) for its Advanced Visualization software, ORS Visual.

FDA Webview Closed for Thanksgiving Break

[ Price : $8.95]

FDA Webview closes 11/25-26 in observance of the annual Thanksgiving holiday break.